QA: Immunogen Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000855654_2022_Immunogen_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0000855654, Immunogen Inc

  xvar xval
0 AssetsCurrent 499,999,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,663,000
3 remainder_Assets 21,103,000
4 LiabilitiesCurrent 100,945,000
5 LiabilitiesNoncurrent 64,267,000
6 remainder_Liabilities 34,967,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 46,289,425
9 ResearchAndDevelopmentExpense 150,449,212
10 remainder_Expenses 17,816,953
11 remainder_Revenues 88,954,628
12 remainder_NetIncome -1,213,437
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 525,765,000
1 Liabilities 200,179,000
2 Expenses 214,555,590
3 Revenues 88,954,628
4 StockholdersEquity 325,586,000
5 NetIncome -126,814,399
6 ComprehensiveNetIncome -126,814,399
7 BaseVar 515,333,828
8 EconomicCapitalRatiobeforeLimitedLiability 1.61
9 EconomicCapitalRatio 2.75

Edgar->Model Mapping

Feature Distribution

Change over Time